Literature DB >> 23046644

Ubiquitin receptors and protein quality control.

Xuejun Wang1, Erin J M Terpstra.   

Abstract

Protein quality control (PQC) is essential to intracellular proteostasis and is carried out by sophisticated collaboration between molecular chaperones and targeted protein degradation. The latter is performed by proteasome-mediated degradation, chaperone-mediated autophagy (CMA), and selective macroautophagy, and collectively serves as the final line of defense of PQC. Ubiquitination and subsequently ubiquitin (Ub) receptor proteins (e.g., p62 and ubiquilins) are important common factors for targeting misfolded proteins to multiple quality control destinies, including the proteasome, lysosomes, and perhaps aggresomes, as well as for triggering mitophagy to remove defective mitochondria. PQC inadequacy, particularly proteasome functional insufficiency, has been shown to participate in cardiac pathogenesis. Tremendous advances have been made in unveiling the changes of PQC in cardiac diseases. However, the investigation into the molecular pathways regulating PQC in cardiac (patho)physiology, including the function of most ubiquitin receptor proteins in the heart, has only recently been initiated. A better understanding of molecular mechanisms governing PQC in cardiac physiology and pathology will undoubtedly provide new insights into cardiac pathogenesis and promote the search for novel therapeutic strategies to more effectively battle heart disease.This article is part of a Special Issue entitled "Focus on Cardiac Metabolism".
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23046644      PMCID: PMC3571097          DOI: 10.1016/j.yjmcc.2012.09.012

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  155 in total

1.  Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress.

Authors:  Ulrike Seifert; Lukasz P Bialy; Frédéric Ebstein; Dawadschargal Bech-Otschir; Antje Voigt; Friederike Schröter; Timour Prozorovski; Nicole Lange; Janos Steffen; Melanie Rieger; Ulrike Kuckelkorn; Orhan Aktas; Peter-M Kloetzel; Elke Krüger
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

Review 2.  Ubiquitin: same molecule, different degradation pathways.

Authors:  Michael J Clague; Sylvie Urbé
Journal:  Cell       Date:  2010-11-24       Impact factor: 41.582

Review 3.  Protein folding and quality control in the endoplasmic reticulum: Recent lessons from yeast and mammalian cell systems.

Authors:  Jeffrey L Brodsky; William R Skach
Journal:  Curr Opin Cell Biol       Date:  2011-06-12       Impact factor: 8.382

4.  Ataxin-3 regulates aggresome formation of copper-zinc superoxide dismutase (SOD1) by editing K63-linked polyubiquitin chains.

Authors:  Hongfeng Wang; Zheng Ying; Guanghui Wang
Journal:  J Biol Chem       Date:  2012-07-03       Impact factor: 5.157

5.  Family-based association between Alzheimer's disease and variants in UBQLN1.

Authors:  Lars Bertram; Mikko Hiltunen; Michele Parkinson; Martin Ingelsson; Christoph Lange; Karunya Ramasamy; Kristina Mullin; Rashmi Menon; Andrew J Sampson; Monica Y Hsiao; Kathryn J Elliott; Gonül Velicelebi; Thomas Moscarillo; Bradley T Hyman; Steven L Wagner; K David Becker; Deborah Blacker; Rudolph E Tanzi
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

6.  Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy.

Authors:  Nickie C Chan; Anna M Salazar; Anh H Pham; Michael J Sweredoski; Natalie J Kolawa; Robert L J Graham; Sonja Hess; David C Chan
Journal:  Hum Mol Genet       Date:  2011-02-04       Impact factor: 6.150

7.  Ubiquilin overexpression reduces GFP-polyalanine-induced protein aggregates and toxicity.

Authors:  Hongmin Wang; Mervyn J Monteiro
Journal:  Exp Cell Res       Date:  2007-04-06       Impact factor: 3.905

8.  Activity and cellular functions of the deubiquitinating enzyme and polyglutamine disease protein ataxin-3 are regulated by ubiquitination at lysine 117.

Authors:  Sokol V Todi; K Matthew Scaglione; Jessica R Blount; Venkatesha Basrur; Kevin P Conlon; Annalisa Pastore; Kojo Elenitoba-Johnson; Henry L Paulson
Journal:  J Biol Chem       Date:  2010-10-13       Impact factor: 5.157

9.  Enhancement of proteasome activity by a small-molecule inhibitor of USP14.

Authors:  Byung-Hoon Lee; Min Jae Lee; Soyeon Park; Dong-Chan Oh; Suzanne Elsasser; Ping-Chung Chen; Carlos Gartner; Nevena Dimova; John Hanna; Steven P Gygi; Scott M Wilson; Randall W King; Daniel Finley
Journal:  Nature       Date:  2010-09-09       Impact factor: 49.962

10.  Exposed hydrophobicity is a key determinant of nuclear quality control degradation.

Authors:  Eric K Fredrickson; Joel C Rosenbaum; Melissa N Locke; Thomas I Milac; Richard G Gardner
Journal:  Mol Biol Cell       Date:  2011-05-05       Impact factor: 4.138

View more
  38 in total

1.  Proteostasis in epicardial versus subcutaneous adipose tissue in heart failure subjects with and without diabetes.

Authors:  A Burgeiro; A C Fonseca; D Espinoza; L Carvalho; N Lourenço; M Antunes; E Carvalho
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-04-04       Impact factor: 5.187

Review 2.  The COP9 signalosome and vascular function: intriguing possibilities?

Authors:  Douglas S Martin; Xuejun Wang
Journal:  Am J Cardiovasc Dis       Date:  2015-03-20

Review 3.  Proteostasis in cardiac health and disease.

Authors:  Robert H Henning; Bianca J J M Brundel
Journal:  Nat Rev Cardiol       Date:  2017-06-29       Impact factor: 32.419

4.  Autophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome.

Authors:  Mi-Hyang Cho; Kwangmin Cho; Hoe-Jin Kang; Eun-Young Jeon; Hun-Sik Kim; Hyung-Joon Kwon; Hong-Mi Kim; Dong-Hou Kim; Seung-Yong Yoon
Journal:  Autophagy       Date:  2014-07-22       Impact factor: 16.016

5.  Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors.

Authors:  Lei Zhang; Maria B Hapon; Alicia A Goyeneche; Rekha Srinivasan; Carlos D Gamarra-Luques; Eduardo A Callegari; Donis D Drappeau; Erin J Terpstra; Bo Pan; Jennifer R Knapp; Jeremy Chien; Xuejun Wang; Kathleen M Eyster; Carlos M Telleria
Journal:  Mol Oncol       Date:  2016-05-17       Impact factor: 6.603

6.  COP9 signalosome controls the degradation of cytosolic misfolded proteins and protects against cardiac proteotoxicity.

Authors:  Huabo Su; Jie Li; Hanming Zhang; Wenxia Ma; Ning Wei; Jinbao Liu; Xuejun Wang
Journal:  Circ Res       Date:  2015-09-17       Impact factor: 17.367

Review 7.  The interplay between autophagy and the ubiquitin-proteasome system in cardiac proteotoxicity.

Authors:  Changhua Wang; Xuejun Wang
Journal:  Biochim Biophys Acta       Date:  2014-08-01

8.  High expression of ubiquitin-conjugating enzyme E2A predicts poor prognosis in hepatocellular carcinoma.

Authors:  Jian-Dong Shen; Shou-Zhong Fu; Lin-Ling Ju; Yi-Fang Wang; Feng Dai; Zhao-Xiu Liu; Han-Zheng Ji; Jian-Guo Shao; Zhao-Lian Bian
Journal:  Oncol Lett       Date:  2018-03-07       Impact factor: 2.967

9.  Ushering in the cardiac role of Ubiquilin1.

Authors:  Xi Fang; Christa Trexler; Ju Chen
Journal:  J Clin Invest       Date:  2018-10-22       Impact factor: 14.808

Review 10.  Proteasomal and lysosomal protein degradation and heart disease.

Authors:  Xuejun Wang; Jeffrey Robbins
Journal:  J Mol Cell Cardiol       Date:  2013-11-14       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.